QQQ   361.72 (-1.30%)
AAPL   164.51 (-1.03%)
MSFT   301.60 (-0.57%)
FB   316.56 (-0.95%)
GOOGL   2,666.15 (-1.34%)
AMZN   3,033.35 (-2.96%)
TSLA   996.27 (+0.06%)
NVDA   241.50 (-3.66%)
BABA   131.03 (+2.58%)
NIO   29.13 (+1.75%)
AMD   121.89 (-4.97%)
CGC   7.56 (-1.05%)
MU   85.07 (-5.48%)
GE   98.25 (-2.36%)
T   27.02 (-0.95%)
F   21.65 (-3.56%)
DIS   147.62 (-1.66%)
AMC   18.07 (-1.36%)
PFE   54.05 (+0.95%)
ACB   4.75 (-2.26%)
BA   214.19 (-1.33%)
QQQ   361.72 (-1.30%)
AAPL   164.51 (-1.03%)
MSFT   301.60 (-0.57%)
FB   316.56 (-0.95%)
GOOGL   2,666.15 (-1.34%)
AMZN   3,033.35 (-2.96%)
TSLA   996.27 (+0.06%)
NVDA   241.50 (-3.66%)
BABA   131.03 (+2.58%)
NIO   29.13 (+1.75%)
AMD   121.89 (-4.97%)
CGC   7.56 (-1.05%)
MU   85.07 (-5.48%)
GE   98.25 (-2.36%)
T   27.02 (-0.95%)
F   21.65 (-3.56%)
DIS   147.62 (-1.66%)
AMC   18.07 (-1.36%)
PFE   54.05 (+0.95%)
ACB   4.75 (-2.26%)
BA   214.19 (-1.33%)
QQQ   361.72 (-1.30%)
AAPL   164.51 (-1.03%)
MSFT   301.60 (-0.57%)
FB   316.56 (-0.95%)
GOOGL   2,666.15 (-1.34%)
AMZN   3,033.35 (-2.96%)
TSLA   996.27 (+0.06%)
NVDA   241.50 (-3.66%)
BABA   131.03 (+2.58%)
NIO   29.13 (+1.75%)
AMD   121.89 (-4.97%)
CGC   7.56 (-1.05%)
MU   85.07 (-5.48%)
GE   98.25 (-2.36%)
T   27.02 (-0.95%)
F   21.65 (-3.56%)
DIS   147.62 (-1.66%)
AMC   18.07 (-1.36%)
PFE   54.05 (+0.95%)
ACB   4.75 (-2.26%)
BA   214.19 (-1.33%)
QQQ   361.72 (-1.30%)
AAPL   164.51 (-1.03%)
MSFT   301.60 (-0.57%)
FB   316.56 (-0.95%)
GOOGL   2,666.15 (-1.34%)
AMZN   3,033.35 (-2.96%)
TSLA   996.27 (+0.06%)
NVDA   241.50 (-3.66%)
BABA   131.03 (+2.58%)
NIO   29.13 (+1.75%)
AMD   121.89 (-4.97%)
CGC   7.56 (-1.05%)
MU   85.07 (-5.48%)
GE   98.25 (-2.36%)
T   27.02 (-0.95%)
F   21.65 (-3.56%)
DIS   147.62 (-1.66%)
AMC   18.07 (-1.36%)
PFE   54.05 (+0.95%)
ACB   4.75 (-2.26%)
BA   214.19 (-1.33%)
NASDAQ:AMEH

Apollo Medical Stock Forecast, Price & News

$53.01
-1.15 (-2.12%)
(As of 01/20/2022 12:00 AM ET)
Add
Compare
Today's Range
$52.79
$57.25
50-Day Range
$54.16
$119.45
52-Week Range
$20.51
$133.23
Volume
277,671 shs
Average Volume
350,499 shs
Market Capitalization
$2.94 billion
P/E Ratio
33.34
Dividend Yield
N/A
Beta
0.16
30 days | 90 days | 365 days | Advanced Chart
Receive AMEH News and Ratings via Email

Sign-up to receive the latest news and ratings for Apollo Medical and its competitors with MarketBeat's FREE daily newsletter.


Apollo Medical logo

About Apollo Medical

Apollo Medical Holdings, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. It focuses on providing population health management and healthcare delivery platform. The company operates as an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner. Apollo Medical Holdings was founded on November 1, 1985 and is headquartered in Alhambra, CA.

Headlines

Apollo Medical (NASDAQ:AMEH) Shares Gap Down to $64.28
January 14, 2022 |  americanbankingnews.com
Apollo Medical Holdings (AMEH)
December 6, 2021 |  forbes.com
MODV or AMEH: Which Is the Better Value Stock Right Now?
December 2, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:AMEH
Employees
769
Year Founded
N/A

Sales & Book Value

Annual Sales
$687.18 million
Cash Flow
$1.02 per share
Book Value
$6.10 per share

Profitability

Net Income
$37.87 million
Pretax Margin
16.54%

Debt

Price-To-Earnings

Miscellaneous

Free Float
48,694,000
Market Cap
$2.94 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
11/04/2021
Today
1/20/2022
Next Earnings (Estimated)
3/09/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.77 out of 5 stars

Medical Sector

884th out of 1,418 stocks

Management Consulting Services Industry

14th out of 26 stocks

Analyst Opinion: 3.3Community Rank: 4.1Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -












Apollo Medical (NASDAQ:AMEH) Frequently Asked Questions

Is Apollo Medical a buy right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Apollo Medical in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Apollo Medical stock.
View analyst ratings for Apollo Medical
or view top-rated stocks.

How has Apollo Medical's stock price been impacted by Coronavirus?

Apollo Medical's stock was trading at $14.07 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, AMEH stock has increased by 276.8% and is now trading at $53.01.
View which stocks have been most impacted by COVID-19
.

When is Apollo Medical's next earnings date?

Apollo Medical is scheduled to release its next quarterly earnings announcement on Wednesday, March 9th 2022.
View our earnings forecast for Apollo Medical
.

How were Apollo Medical's earnings last quarter?

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) posted its quarterly earnings data on Thursday, November, 4th. The company reported $0.69 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.34 by $0.35. The firm earned $227.12 million during the quarter. Apollo Medical had a trailing twelve-month return on equity of 18.39% and a net margin of 9.28%. During the same quarter in the prior year, the business earned $0.45 earnings per share.
View Apollo Medical's earnings history
.

What guidance has Apollo Medical issued on next quarter's earnings?

Apollo Medical issued an update on its FY 2021 earnings guidance on Thursday, December, 2nd. The company provided earnings per share guidance of $1.580-$1.620 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.220. The company issued revenue guidance of $751.50 million-$758.50 million, compared to the consensus revenue estimate of $704.86 million.

What price target have analysts set for AMEH?

2 Wall Street analysts have issued 1 year price targets for Apollo Medical's stock. Their forecasts range from $75.00 to $92.00. On average, they anticipate Apollo Medical's stock price to reach $83.50 in the next year. This suggests a possible upside of 57.5% from the stock's current price.
View analysts' price targets for Apollo Medical
or view top-rated stocks among Wall Street analysts.

Who are Apollo Medical's key executives?

Apollo Medical's management team includes the following people:
  • Thomas S. Lam, President, Co-Chief Executive Officer & Director
  • Brandon Sim, Co-Chief Executive Officer (LinkedIn Profile)
  • Eric Chin, Chief Financial Officer & Secretary
  • Albert Young, Chief Administration Officer
  • Jeremy R. Jackson, Chief Quality Officer

What is Thomas Lam's approval rating as Apollo Medical's CEO?

9 employees have rated Apollo Medical CEO Thomas Lam on Glassdoor.com. Thomas Lam has an approval rating of 43% among Apollo Medical's employees. This puts Thomas Lam in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Apollo Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apollo Medical investors own include PayPal (PYPL), SEA (SE), Mastercard (MA), NVIDIA (NVDA), Walt Disney (DIS), Lululemon Athletica (LULU), Enphase Energy (ENPH), Main Street Capital (MAIN), Square (SQ) and Exxon Mobil (XOM).

What is Apollo Medical's stock symbol?

Apollo Medical trades on the NASDAQ under the ticker symbol "AMEH."

Who are Apollo Medical's major shareholders?

Apollo Medical's stock is owned by a number of retail and institutional investors. Top institutional shareholders include State of Alaska Department of Revenue (0.05%), Louisiana State Employees Retirement System (0.03%), Crossmark Global Holdings Inc. (0.01%) and Lindbrook Capital LLC (0.00%). Company insiders that own Apollo Medical stock include Adrian Vazquez, Albert Waichow Young, Brandon Sim, Eric Chin, Physicians Of Californi Allied and Thomas S Lam.
View institutional ownership trends for Apollo Medical
.

Which major investors are selling Apollo Medical stock?

AMEH stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. Company insiders that have sold Apollo Medical company stock in the last year include Albert Waichow Young, and Physicians Of Californi Allied.
View insider buying and selling activity for Apollo Medical
or view top insider-selling stocks.

Which major investors are buying Apollo Medical stock?

AMEH stock was acquired by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., Lindbrook Capital LLC, and Louisiana State Employees Retirement System. Company insiders that have bought Apollo Medical stock in the last two years include Brandon Sim, Eric Chin, Physicians Of Californi Allied, and Thomas S Lam.
View insider buying and selling activity for Apollo Medical
or or view top insider-buying stocks.

How do I buy shares of Apollo Medical?

Shares of AMEH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apollo Medical's stock price today?

One share of AMEH stock can currently be purchased for approximately $53.01.

How much money does Apollo Medical make?

Apollo Medical has a market capitalization of $2.94 billion and generates $687.18 million in revenue each year. The company earns $37.87 million in net income (profit) each year or $1.59 on an earnings per share basis.

How many employees does Apollo Medical have?

Apollo Medical employs 769 workers across the globe.

What is Apollo Medical's official website?

The official website for Apollo Medical is www.apollomed.net.

Where are Apollo Medical's headquarters?

Apollo Medical is headquartered at 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801.

How can I contact Apollo Medical?

Apollo Medical's mailing address is 1668 S. GARFIELD AVENUE 2ND FLOOR, ALHAMBRA CA, 91801. The company can be reached via phone at (626) 943-6491, via email at [email protected], or via fax at 818-839-5190.


This page was last updated on 1/20/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.